Tudor Investment Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,301,716
| Closed | -$34.7M | – | 4128 |
|
|
2025
Q4 | $32.4M | Buy |
1,301,716
+1,120,503
| +618% | +$28.3M | 0.06% | 264 |
|
|
2025
Q3 | $4.62M | Buy |
+181,213
| New | +$4.47M | 0.01% | 1240 |
|
|
2025
Q2 | – | Sell |
-1,156,325
| Closed | -$27M | – | 3642 |
|
|
2025
Q1 | $29.3M | Buy |
+1,156,325
| New | +$30.3M | 0.1% | 130 |
|
|
2024
Q4 | – | Sell |
-43,852
| Closed | -$1.19M | – | 3397 |
|
|
2024
Q3 | $1.27M | Sell |
43,852
-166,123
| -79% | -$4.85M | ﹤0.01% | 1481 |
|
|
2024
Q2 | $5.88M | Buy |
+209,975
| New | +$5.78M | 0.03% | 597 |
|
|
2024
Q1 | – | Sell |
-372,691
| Closed | -$10.3M | – | 2653 |
|
|
2023
Q4 | $10.7M | Buy |
+372,691
| New | +$11.3M | 0.09% | 323 |
|
|
2023
Q3 | – | Sell |
-298,246
| Closed | -$10.5M | – | 2730 |
|
|
2023
Q2 | $10.9M | Buy |
298,246
+195,437
| +190% | +$7.61M | 0.13% | 154 |
|
|
2023
Q1 | $4.2M | Buy |
102,809
+86,799
| +542% | +$3.75M | 0.06% | 450 |
|
|
2022
Q4 | $820K | Sell |
16,010
-188,949
| -92% | -$9.06M | 0.02% | 1247 |
|
|
2022
Q3 | $8.97M | Buy |
+204,959
| New | +$9.96M | 0.19% | 99 |
|
|
2022
Q2 | – | Sell |
-46,169
| Closed | -$2.39M | – | 2421 |
|
|
2022
Q1 | $2.39M | Buy |
46,169
+20,243
| +78% | +$1.05M | 0.06% | 466 |
|
|
2021
Q4 | $1.53M | Sell |
25,926
-32,143
| -55% | -$1.59M | 0.03% | 771 |
|
|
2021
Q3 | $2.5M | Buy |
58,069
+36,332
| +167% | +$1.61M | 0.04% | 578 |
|
|
2021
Q2 | $851K | Sell |
21,737
-25,880
| -54% | -$1.01M | 0.02% | 930 |
|
|
2021
Q1 | $1.73M | Buy |
47,617
+2,306
| +5% | +$81.9K | 0.03% | 587 |
|
|
2020
Q4 | $1.67M | Sell |
45,311
-45,547
| -50% | -$1.67M | 0.05% | 489 |
|
|
2020
Q3 | $3.16M | Buy |
90,858
+20,440
| +29% | +$717K | 0.14% | 161 |
|
|
2020
Q2 | $2.19M | Buy |
+70,418
| New | +$2.39M | 0.11% | 225 |
|
|
2020
Q1 | – | Sell |
-166,195
| Closed | -$6.18M | – | 1253 |
|
|
2019
Q4 | $6.18M | Buy |
166,195
+150,091
| +932% | +$5.35M | 0.28% | 65 |
|
|
2019
Q3 | $549K | Buy |
+16,104
| New | +$586K | 0.02% | 691 |
|
|
2018
Q3 | – | Sell |
-29,754
| Closed | -$1.02M | – | 1208 |
|
|
2018
Q2 | $1.02M | Buy |
+29,754
| New | +$1.02M | 0.04% | 432 |
|
|
2018
Q1 | – | Sell |
-26,493
| Closed | -$910K | – | 1180 |
|
|
2017
Q4 | $910K | Buy |
+26,493
| New | +$903K | 0.02% | 380 |
|
|
2017
Q2 | – | Sell |
-6,746
| Closed | -$219K | – | 1292 |
|
|
2017
Q1 | $219K | Sell |
6,746
-4,743
| -41% | -$150K | 0.01% | 1183 |
|
|
2016
Q4 | $354K | Sell |
11,489
-6,640
| -37% | -$203K | 0.01% | 922 |
|
|
2016
Q3 | $583K | Sell |
18,129
-4,532
| -20% | -$152K | 0.01% | 655 |
|
|
2016
Q2 | $757K | Buy |
22,661
+7,273
| +47% | +$232K | 0.02% | 583 |
|
|
2016
Q1 | $433K | Sell |
15,388
-21,397
| -58% | -$611K | 0.01% | 1054 |
|
|
2015
Q4 | $1.13M | Buy |
36,785
+6,957
| +23% | +$219K | 0.03% | 400 |
|
|
2015
Q3 | $889K | Buy |
29,828
+13,386
| +81% | +$429K | 0.03% | 434 |
|
|
2015
Q2 | $523K | Sell |
16,442
-1,183,627
| -99% | -$38.6M | 0.02% | 747 |
|
|
2015
Q1 | $39.6M | Buy |
1,200,069
+793,752
| +195% | +$25.2M | 1.27% | 6 |
|
|
2014
Q4 | $12M | Buy |
406,317
+294,870
| +265% | +$8.45M | 0.42% | 32 |
|
|
2014
Q3 | $3.13M | Buy |
111,447
+94,372
| +553% | +$2.65M | 0.11% | 99 |
|
|
2014
Q2 | $481K | Sell |
17,075
-905,175
| -98% | -$25.8M | 0.02% | 559 |
|
|
2014
Q1 | $28.1M | Buy |
922,250
+873,506
| +1,792% | +$26M | 1.19% | 10 |
|
|
2013
Q4 | $1.42M | Sell |
48,744
-952,556
| -95% | -$27.7M | 0.07% | 128 |
|
|
2013
Q3 | $27.3M | Buy |
1,001,300
+792,924
| +381% | +$21.6M | 1.12% | 11 |
|
|
2013
Q2 | $5.54M | Buy |
+208,376
| New | +$5.76M | 0.42% | 58 |
|
Other funds holding PFE
VCM
VPM
Tudor Investment Corp's PFE Position: Q1 2026 in Review
Tudor Investment Corp sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,301,716 shares — an estimated $34.7M sold.
Tudor Investment Corp first reported a position in PFE in Q2 2013 and held it in 38 quarters. The position peaked at $39.6M in Q1 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Tudor Investment Corp reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Tudor Investment Corp sold 1,301,716 Pfizer shares in Q1 2026, an estimated $34.7M.
- Tudor Investment Corp first reported a position in Pfizer in Q2 2013 and held it in 38 quarters.
- Tudor Investment Corp's Pfizer position peaked at $39.6M in Q1 2015.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.